GUTS

Fractyl Health, Inc. (GUTS) is an innovative metabolic therapeutics company based in Lexington, Massachusetts, focused on revolutionizing the treatment of type 2 diabetes (T2D) and obesity. With a strong emphasis on cutting-edge research and development, Fractyl is dedicated to creating therapies that target the underlying causes of these widespread conditions, thereby enhancing long-term health outcomes for patients. The company's strategic vision and commitment to advancing metabolic health position it as a significant contributor within the biopharmaceutical sector, with the potential to shift treatment paradigms and improve the quality of life for patients globally.